Mark Higgins

4.4k citations
73 papers · 2.9k · 1 hit paper · h-index 26

Impact in

    • Cystic Fibrosis Research Advances
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Neonatal Respiratory Health Research
    • Inhalation and Respiratory Drug Delivery
    • Tracheal and airway disorders
    • Respiratory Support and Mechanisms
    • Respiratory and Cough-Related Research
  • Physiology top 2%
    • Asthma and respiratory diseases

Papers in

    • Cystic Fibrosis Research Advances 23
    • Chronic Obstructive Pulmonary Disease (COPD) Research 22
    • Inhalation and Respiratory Drug Delivery 10
    • Respiratory Support and Mechanisms 9
    • Neonatal Respiratory Health Research 4
    • Asthma and respiratory diseases 14

Mark Higgins

67 papers receiving 2.7k citations

Mark Higgins's Hit Papers

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation 2014 · 281 citations
2810+4+8Years since publication50100150200250

Peers

Mark Higgins
Comparison fields: 5 of 111
  • Pulmonary and Respiratory Medicine 2.3k
  • Physiology 717
  • Molecular Medicine 44
  • Issues, ethics and legal aspects 10
  • Statistics and Probability 62
Replace Thomas J. Hwang with:
Thomas J. Hwang United States
Michael P. Douglas United States
Edward D. Lustbader United States
Jeongeun Kim South Korea
Stephen J. Jay United States
Hyun Young Koo South Korea
Roberta Pastorino Italy
Mark R. Wakefield United States
Catherine H. Marshall United States
Navkiran K. Shokar United States
Mark Higgins relative to Thomas J. Hwang United States Thomas J. Hwang's profile →
Citations per field
00.5×10×20×30×35.1×
Thomas J. Hwang · 1×
Citations per year

Countries citing papers authored by Mark Higgins

Since Specialization
Citations

This map shows the geographic impact of Mark Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Higgins more than expected).

Fields of papers citing papers by Mark Higgins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Higgins. The network helps show where Mark Higgins may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Higgins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Higgins Line = papers co-authored together Mark Higgins links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
Hit paper breakdown →
2014281
2 2010274
3 2010257
4 2010215
5 2019193
6 2015177
7 2018150
8 2010101
9 201994
10 201081
11 199777
12 200871
13 200667
14 201066
15 199560
16 200749
17 201738
18 201338
19 200736
20 200735

About Mark Higgins

Mark Higgins is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Accounting, Cardiology and Cardiovascular Medicine and Animal Science and Zoology, having authored 73 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Asthma and respiratory diseases (14 papers), Inhalation and Respiratory Drug Delivery (10 papers), Respiratory Support and Mechanisms (9 papers), Neonatal Respiratory Health Research (4 papers), Pharmacological Effects and Assays (3 papers) and Pediatric health and respiratory diseases (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.3k citations), Physiology (717 citations), Molecular Medicine (44 citations), Issues, ethics and legal aspects (10 citations) and Statistics and Probability (62 citations). Mark Higgins has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Roger Owen, Benjamin Krämer, Michael W. Konstan, Damon Jack, Patrick A. Flume, K. De Boeck, Amir Iqbal, À. Munck, Seth Walker and Peter Hiatt. Their work appears in journals such as Journal of Cystic Fibrosis, Respiratory Medicine, Thorax, Pulmonary Pharmacology & Therapeutics and Current Medical Research and Opinion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact